Aripiprazole in Patients With Acute Mania

Completed · Phase 3

Conditions studied: Bipolar Disorder

In brief

The purpose of this trial is to test the safety \& efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.

Key facts

Study ID
NCT00095511
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
615
Starts
2004-06-01
Expected to finish
2007-05-01
Last updated by the study team
2013-11-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.